Clinical Characterization of a National Cohort of Patients With Germline WT1 Variants Including Late-Onset Phenotypes
2024

Study of Patients with WT1 Variants and Kidney Issues

Sample size: 43 publication Evidence: moderate

Author Information

Author(s): Sophie E. van Peer, Roland P. Kuiper, Janna A. Hol, Sanne Egging, Bert van der Zwaag, Marc R. Lilien, M. Paola Lombardi, Marry M. van den Heuvel-Eibrink, Marjolijn C.J. Jongmans

Primary Institution: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Hypothesis

What is the genotype-phenotype correlation in patients with germline WT1 variants?

Conclusion

Patients with WT1 variants show a correlation between their genotype and the risk of developing Wilms tumor and chronic kidney disease (CKD).

Supporting Evidence

  • 60% of patients developed Wilms tumor, which is higher than in previous studies.
  • All patients with missense variants developed chronic kidney disease (CKD).
  • Kidney failure occurred in 51% of patients.
  • Patients with truncating variants had the highest frequency of Wilms tumor occurrence.

Takeaway

This study looked at kids with a specific gene change that can cause kidney problems and tumors, finding that some kids might get sick later in life even if they seem fine now.

Methodology

Clinical and genetic data were collected from all patients with germline WT1 variants at Dutch genetic laboratories.

Potential Biases

There may be bias due to the selection of patients based on known WT1-related phenotypes.

Limitations

The study is limited by the rarity of WT1 variants, retrospective data collection, and potential bias in patient selection.

Participant Demographics

The cohort included 43 patients, with 16 males and 27 females.

Digital Object Identifier (DOI)

10.1016/j.ekir.2024.09.007

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication